HopeAI is on a mission to bring hope to patients by accelerating the clinical development of life-saving treatments through the power of AI. HopeAI is the only Mayo Clinic Platform_Accelerate company that specializes in clinical trial design. By integrating comprehensive clinical evidence with cutting-edge statistical innovations, HopeAI enables pharma partners to design smaller, faster, and more successful clinical trials. HopeAI is partnering with two of the top 10 pharma companies and an increasing number of biotech companies to optimize their clinical trials